19692-00-3,
N-Thiazol-2-yl-succinamic acid,
n-thiazol-2-ylsuccinamic acid,
3-[(1,3-thiazol-2-yl)carbamoyl]propanoic acid,
4-oxo-4-(1,3-thiazol-2-ylamino)butanoic acid,
4-oxo-4-(thiazol-2-ylamino)butanoic acid,
Butanoicacid, 4-oxo-4-(2-thiazolylamino)-,
3-(N-(1,3-thiazol-2-yl)carbamoyl)propanoic acid,
NSC80809,
AC1L5S8N,
AC1Q5NY8,
Oprea1_057043,
Oprea1_497240,
Oprea1_526854,
AC1Q756I,
IFLab1_000192,
SCHEMBL6252743,
CTK0I4054,
n-(2-thiazolyl) succinamic acid,
DTXSID60292202,
HMS1412I16,
HMS1769A01,
ZINC5522054,
6628AD,
CCG-40389,
NSC-80809,
SBB007469,
STK293181,
AKOS000300976,
AKOS003616095,
MCULE-7325471378,
N-(2-THIAZOLYL)SUCCINAMIC ACID,
NE49165,
SDCCGMLS-0065441.P001,
IDI1_008411,
AJ-70371,
BAS 00500340,
ST058652,
4-Oxo-4-(thiazole-2-ylamino)butanoic acid,
TR-040259,
3-(1,3-thiazol-2-ylcarbamoyl)propanoic acid,
EN300-38853,
J3.543.455K,
SR-01000313675,
J-012730,
SR-01000313675-1,
Z56759043,
F0017-0486,
4-oxo-4-[(2E)-1,3-thiazol-2(3H)-ylideneamino]butanoic acid,
C7H8N2O3S,
2-(3-Carboxypropionylamino)thiazole,
AR-1C7224,
CID255363,
22541-90-8,